1.Linear Association between Frailty as Assessed by the Kihon Checklist and Quality of Life in Community-Dwelling Older Adults: A Cross-Sectional Population-Based Study
Suguru SHIMOKIHARA ; Kazuki YOKOYAMA ; Hikaru IHIRA ; Yuriko MATSUZAKI-KIHARA ; Atsushi MIZUMOTO ; Hideyuki TASHIRO ; Hidekazu SAITO ; Keitaro MAKINO ; Kiyotaka SHIMADA ; Kosuke YAMA ; Ryo MIYAJIMA ; Takeshi SASAKI ; Nozomu IKEDA
Annals of Geriatric Medicine and Research 2025;29(1):66-74
		                        		
		                        			 Background:
		                        			The need for support focused on frailty and quality of life (QoL) in older adults is increasing. The Kihon Checklist (KCL) is a comprehensive and easy-to-use tool to assess frailty in older adults. Previous studies have shown associations between frailty and QoL; however, few studies have investigated the association between frailty using the KCL and QoL. In this study, the quantitative relationship between the KCL and QoL in community-dwelling older adults was investigated. 
		                        		
		                        			Methods:
		                        			This cross-sectional study included from participants in the 2017–2019 baseline survey of a cohort study of community-dwelling older adults in Sapporo, Japan. The World Health Organization-Five Well-Being Index (WHO-5) was used to assess QoL. The KCL was used to assess frailty, and the relationship between frailty and QoL was examined using binomial logistic regression analysis and restricted cubic spline models. 
		                        		
		                        			Results:
		                        			Four-hundred participants were included in the analysis. Of the participants, 22.5% had a lower QoL and they were more likely to have frailty than healthy participants (p<0.001). The KCL scores were significantly associated with a lower QoL (p<0.001). Furthermore, the association between the KCL score and QoL was linear, and subscales of activities of daily living, and depressive mood were significantly associated with a lower QoL. 
		                        		
		                        			Conclusion
		                        			The KCL, a comprehensive frailty questionnaire, was associated with a lower QoL in older adults. To maintain QoL in community-dwelling older adults, it is necessary to provide them with appropriate support from the stage before they are identified as frail by the KCL. 
		                        		
		                        		
		                        		
		                        	
2.Linear Association between Frailty as Assessed by the Kihon Checklist and Quality of Life in Community-Dwelling Older Adults: A Cross-Sectional Population-Based Study
Suguru SHIMOKIHARA ; Kazuki YOKOYAMA ; Hikaru IHIRA ; Yuriko MATSUZAKI-KIHARA ; Atsushi MIZUMOTO ; Hideyuki TASHIRO ; Hidekazu SAITO ; Keitaro MAKINO ; Kiyotaka SHIMADA ; Kosuke YAMA ; Ryo MIYAJIMA ; Takeshi SASAKI ; Nozomu IKEDA
Annals of Geriatric Medicine and Research 2025;29(1):66-74
		                        		
		                        			 Background:
		                        			The need for support focused on frailty and quality of life (QoL) in older adults is increasing. The Kihon Checklist (KCL) is a comprehensive and easy-to-use tool to assess frailty in older adults. Previous studies have shown associations between frailty and QoL; however, few studies have investigated the association between frailty using the KCL and QoL. In this study, the quantitative relationship between the KCL and QoL in community-dwelling older adults was investigated. 
		                        		
		                        			Methods:
		                        			This cross-sectional study included from participants in the 2017–2019 baseline survey of a cohort study of community-dwelling older adults in Sapporo, Japan. The World Health Organization-Five Well-Being Index (WHO-5) was used to assess QoL. The KCL was used to assess frailty, and the relationship between frailty and QoL was examined using binomial logistic regression analysis and restricted cubic spline models. 
		                        		
		                        			Results:
		                        			Four-hundred participants were included in the analysis. Of the participants, 22.5% had a lower QoL and they were more likely to have frailty than healthy participants (p<0.001). The KCL scores were significantly associated with a lower QoL (p<0.001). Furthermore, the association between the KCL score and QoL was linear, and subscales of activities of daily living, and depressive mood were significantly associated with a lower QoL. 
		                        		
		                        			Conclusion
		                        			The KCL, a comprehensive frailty questionnaire, was associated with a lower QoL in older adults. To maintain QoL in community-dwelling older adults, it is necessary to provide them with appropriate support from the stage before they are identified as frail by the KCL. 
		                        		
		                        		
		                        		
		                        	
3.Linear Association between Frailty as Assessed by the Kihon Checklist and Quality of Life in Community-Dwelling Older Adults: A Cross-Sectional Population-Based Study
Suguru SHIMOKIHARA ; Kazuki YOKOYAMA ; Hikaru IHIRA ; Yuriko MATSUZAKI-KIHARA ; Atsushi MIZUMOTO ; Hideyuki TASHIRO ; Hidekazu SAITO ; Keitaro MAKINO ; Kiyotaka SHIMADA ; Kosuke YAMA ; Ryo MIYAJIMA ; Takeshi SASAKI ; Nozomu IKEDA
Annals of Geriatric Medicine and Research 2025;29(1):66-74
		                        		
		                        			 Background:
		                        			The need for support focused on frailty and quality of life (QoL) in older adults is increasing. The Kihon Checklist (KCL) is a comprehensive and easy-to-use tool to assess frailty in older adults. Previous studies have shown associations between frailty and QoL; however, few studies have investigated the association between frailty using the KCL and QoL. In this study, the quantitative relationship between the KCL and QoL in community-dwelling older adults was investigated. 
		                        		
		                        			Methods:
		                        			This cross-sectional study included from participants in the 2017–2019 baseline survey of a cohort study of community-dwelling older adults in Sapporo, Japan. The World Health Organization-Five Well-Being Index (WHO-5) was used to assess QoL. The KCL was used to assess frailty, and the relationship between frailty and QoL was examined using binomial logistic regression analysis and restricted cubic spline models. 
		                        		
		                        			Results:
		                        			Four-hundred participants were included in the analysis. Of the participants, 22.5% had a lower QoL and they were more likely to have frailty than healthy participants (p<0.001). The KCL scores were significantly associated with a lower QoL (p<0.001). Furthermore, the association between the KCL score and QoL was linear, and subscales of activities of daily living, and depressive mood were significantly associated with a lower QoL. 
		                        		
		                        			Conclusion
		                        			The KCL, a comprehensive frailty questionnaire, was associated with a lower QoL in older adults. To maintain QoL in community-dwelling older adults, it is necessary to provide them with appropriate support from the stage before they are identified as frail by the KCL. 
		                        		
		                        		
		                        		
		                        	
4.Hokkaido birth cohort study on environment and children's health: cohort profile 2021.
Reiko KISHI ; Atsuko IKEDA-ARAKI ; Chihiro MIYASHITA ; Sachiko ITOH ; Sumitaka KOBAYASHI ; Yu AIT BAMAI ; Keiko YAMAZAKI ; Naomi TAMURA ; Machiko MINATOYA ; Rahel Mesfin KETEMA ; Kritika POUDEL ; Ryu MIURA ; Hideyuki MASUDA ; Mariko ITOH ; Takeshi YAMAGUCHI ; Hisanori FUKUNAGA ; Kumiko ITO ; Houman GOUDARZI
Environmental Health and Preventive Medicine 2021;26(1):59-59
		                        		
		                        			BACKGROUND:
		                        			The Hokkaido Study on Environment and Children's Health is an ongoing study consisting of two birth cohorts of different population sizes: the Sapporo cohort and the Hokkaido cohort. Our primary objectives are to (1) examine the effects that low-level environmental chemical exposures have on birth outcomes, including birth defects and growth retardation; (2) follow the development of allergies, infectious diseases, and neurobehavioral developmental disorders, as well as perform a longitudinal observation of child development; (3) identify high-risk groups based on genetic susceptibility to environmental chemicals; and (4) identify the additive effects of various chemicals, including tobacco.
		                        		
		                        			METHODS:
		                        			The purpose of this report is to provide an update on the progress of the Hokkaido Study, summarize recent results, and suggest future directions. In particular, this report provides the latest details from questionnaire surveys, face-to-face examinations, and a collection of biological specimens from children and measurements of their chemical exposures.
		                        		
		                        			RESULTS:
		                        			The latest findings indicate different risk factors of parental characteristics on birth outcomes and the mediating effect between socioeconomic status and children that are small for the gestational age. Maternal serum folate was not associated with birth defects. Prenatal chemical exposure and smoking were associated with birth size and growth, as well as cord blood biomarkers, such as adiponectin, leptin, thyroid, and reproductive hormones. We also found significant associations between the chemical levels and neuro development, asthma, and allergies.
		                        		
		                        			CONCLUSIONS
		                        			Chemical exposure to children can occur both before and after birth. Longer follow-up for children is crucial in birth cohort studies to reinforce the Developmental Origins of Health and Disease hypothesis. In contrast, considering shifts in the exposure levels due to regulation is also essential, which may also change the association to health outcomes. This study found that individual susceptibility to adverse health effects depends on the genotype. Epigenome modification of DNA methylation was also discovered, indicating the necessity of examining molecular biology perspectives. International collaborations can add a new dimension to the current knowledge and provide novel discoveries in the future.
		                        		
		                        		
		                        		
		                        			Biomarkers/blood*
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child Health
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Environmental Exposure/adverse effects*
		                        			;
		                        		
		                        			Environmental Health
		                        			;
		                        		
		                        			Environmental Pollutants/adverse effects*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fetal Blood/chemistry*
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Growth/drug effects*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity/etiology*
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Japan/epidemiology*
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Neurodevelopmental Disorders/etiology*
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Prenatal Exposure Delayed Effects/etiology*
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Smoking/adverse effects*
		                        			
		                        		
		                        	
5.Virtual Monochromatic Image Quality from Dual-Layer Dual-Energy Computed Tomography for Detecting Brain Tumors
Shota TANOUE ; Takeshi NAKAURA ; Yasunori NAGAYAMA ; Hiroyuki UETANI ; Osamu IKEDA ; Yasuyuki YAMASHITA
Korean Journal of Radiology 2021;22(6):951-958
		                        		
		                        			Objective:
		                        			To evaluate the usefulness of virtual monochromatic images (VMIs) obtained using dual-layer dual-energy CT (DL-DECT) for evaluating brain tumors. 
		                        		
		                        			Materials and Methods:
		                        			This retrospective study included 32 patients with brain tumors who had undergone non-contrast head CT using DL-DECT. Among them, 15 had glioblastoma (GBM), 7 had malignant lymphoma, 5 had high-grade glioma other than GBM, 3 had low-grade glioma, and 2 had metastatic tumors. Conventional polychromatic images and VMIs (40–200 keV at 10 keV intervals) were generated. We compared CT attenuation, image noise, contrast, and contrast-to-noise ratio (CNR) between tumor and white matter (WM) or grey matter (GM) between VMIs showing the highest CNR (optimized VMI) and conventional CT images using the paired t test. Two radiologists subjectively assessed the contrast, margin, noise, artifact, and diagnostic confidence of optimized VMIs and conventional images on a 4-point scale. 
		                        		
		                        			Results:
		                        			The image noise of VMIs at all energy levels tested was significantly lower than that of conventional CT images (p < 0.05). The 40-keV VMIs yielded the best CNR. Furthermore, both contrast and CNR between the tumor and WM were significantly higher in the 40 keV images than in the conventional CT images (p < 0.001); however, the contrast and CNR between tumor and GM were not significantly different (p = 0.47 and p = 0.31, respectively). The subjective scores assigned to contrast, margin, and diagnostic confidence were significantly higher for 40 keV images than for conventional CT images (p < 0.01). 
		                        		
		                        			Conclusion
		                        			In head CT for patients with brain tumors, compared with conventional CT images, 40 keV VMIs from DL-DECT yielded superior tumor contrast and diagnostic confidence, especially for brain tumors located in the WM.
		                        		
		                        		
		                        		
		                        	
6.Virtual Monochromatic Image Quality from Dual-Layer Dual-Energy Computed Tomography for Detecting Brain Tumors
Shota TANOUE ; Takeshi NAKAURA ; Yasunori NAGAYAMA ; Hiroyuki UETANI ; Osamu IKEDA ; Yasuyuki YAMASHITA
Korean Journal of Radiology 2021;22(6):951-958
		                        		
		                        			Objective:
		                        			To evaluate the usefulness of virtual monochromatic images (VMIs) obtained using dual-layer dual-energy CT (DL-DECT) for evaluating brain tumors. 
		                        		
		                        			Materials and Methods:
		                        			This retrospective study included 32 patients with brain tumors who had undergone non-contrast head CT using DL-DECT. Among them, 15 had glioblastoma (GBM), 7 had malignant lymphoma, 5 had high-grade glioma other than GBM, 3 had low-grade glioma, and 2 had metastatic tumors. Conventional polychromatic images and VMIs (40–200 keV at 10 keV intervals) were generated. We compared CT attenuation, image noise, contrast, and contrast-to-noise ratio (CNR) between tumor and white matter (WM) or grey matter (GM) between VMIs showing the highest CNR (optimized VMI) and conventional CT images using the paired t test. Two radiologists subjectively assessed the contrast, margin, noise, artifact, and diagnostic confidence of optimized VMIs and conventional images on a 4-point scale. 
		                        		
		                        			Results:
		                        			The image noise of VMIs at all energy levels tested was significantly lower than that of conventional CT images (p < 0.05). The 40-keV VMIs yielded the best CNR. Furthermore, both contrast and CNR between the tumor and WM were significantly higher in the 40 keV images than in the conventional CT images (p < 0.001); however, the contrast and CNR between tumor and GM were not significantly different (p = 0.47 and p = 0.31, respectively). The subjective scores assigned to contrast, margin, and diagnostic confidence were significantly higher for 40 keV images than for conventional CT images (p < 0.01). 
		                        		
		                        			Conclusion
		                        			In head CT for patients with brain tumors, compared with conventional CT images, 40 keV VMIs from DL-DECT yielded superior tumor contrast and diagnostic confidence, especially for brain tumors located in the WM.
		                        		
		                        		
		                        		
		                        	
7.Nonspecific Inflammatory Aortic Regurgitation Diagnosed after Aortic Valve Replacement
Yosuke IKEDA ; Yuhei SAITOH ; Naoki SUMI ; Shingo ISHIGURO ; Takeshi SOEDA ; Yoshinobu NAKAMURA
Japanese Journal of Cardiovascular Surgery 2021;50(4):265-269
		                        		
		                        			
		                        			A case of clinical1y unsuspected nonspecific inflammatory aortic regurgitation is reported. A 69-year-old female patient underwent aortic valve replacement for aortic regurgitation. Pathological examination of resected aortic valve showed abscess formation and inflammatory granulation tissue in the non-coronary cusp. Therefore, we diagnosed nonspecific inflammatory aortic regurgitation. It is generally considered that the use of prednisolone for vasculitis syndrome is effective ; however, for nonspecific inflammatory aortic regurgitation its use has not been established. Prednisolone treatment could be an option for nonspecific inflammatory aortic regurgitation.
		                        		
		                        		
		                        		
		                        	
8.Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease.
Tatsuya HAYASHI ; Satoshi SAITOH ; Kei FUKUZAWA ; Yoshinori TSUJI ; Junji TAKAHASHI ; Yusuke KAWAMURA ; Norio AKUTA ; Masahiro KOBAYASHI ; Kenji IKEDA ; Takeshi FUJII ; Tosiaki MIYATI ; Hiromitsu KUMADA
Gut and Liver 2017;11(5):674-683
		                        		
		                        			
		                        			BACKGROUND/AIMS: Noninvasive liver fibrosis evaluation was performed in patients with nonalcoholic fatty liver disease (NAFLD). We used a quantitative method based on the hepatic volume acquired from gadoxetate disodium-enhanced (Gd-EOB-DTPA-enhanced) magnetic resonance imaging (MRI) for diagnosing advanced fibrosis in patients with NAFLD. METHODS: A total of 130 patients who were diagnosed with NAFLD and underwent Gd-EOB-DTPA-enhanced MRI were retrospectively included. Histological data were available for 118 patients. Hepatic volumetric parameters, including the left hepatic lobe to right hepatic lobe volume ratio (L/R ratio), were measured. The usefulness of the L/R ratio for diagnosing fibrosis ≥F3–4 and F4 was assessed using the area under the receiver operating characteristic (AUROC) curve. Multiple regression analysis was performed to identify variables (age, body mass index, serum fibrosis markers, and histological features) that were associated with the L/R ratio. RESULTS: The L/R ratio demonstrated good performance in differentiating advanced fibrosis (AUROC, 0.80; 95% confidence interval, 0.72 to 0.88) from cirrhosis (AUROC, 0.87; 95% confidence interval, 0.75 to 0.99). Multiple regression analysis showed that only fibrosis was significantly associated with the L/R ratio (coefficient, 0.121; p<0.0001). CONCLUSIONS: The L/R ratio, which is not influenced by pathological parameters other than fibrosis, is useful for diagnosing cirrhosis in patients with NAFLD.
		                        		
		                        		
		                        		
		                        			Body Mass Index
		                        			;
		                        		
		                        			Fibrosis*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver Cirrhosis
		                        			;
		                        		
		                        			Magnetic Resonance Imaging
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Non-alcoholic Fatty Liver Disease*
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			ROC Curve
		                        			
		                        		
		                        	
9.The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes.
Yoshiaki KUBOTA ; Masaaki MIYAMOTO ; Gen TAKAGI ; Takeshi IKEDA ; Sonoko KIRINOKI-ICHIKAWA ; Kotoko TANAKA ; Kyoichi MIZUNO
Journal of Korean Medical Science 2012;27(11):1364-1370
		                        		
		                        			
		                        			The vascular endothelial function is impaired in the very early stage of atherosclerosis in diabetic patients. The goal of this study was to identify the mechanism underlying the improvement in vascular endothelial function by sitagliptin in type 2 diabetes mellitus patients. This study was an open-labeled prospective observational single arm trial. Forty patients were treated with 50 mg of sitagliptin once daily for 12-weeks. The flow-mediated dilation (FMD) and plasma adiponectin were measured at baseline and 12 weeks after initiating treatment. The %FMD was significantly increased after treatment (4.13 +/- 1.59 vs 5.12 +/- 1.55, P < 0.001), whereas the nitroglycerin-mediated dilation (NMD) did not change. The plasma adiponectin levels significantly increased (13.0 +/- 11.3 vs 14.3 +/- 12.8, P < 0.001). The changes in the FMD were significantly correlated with those of the plasma adiponectin (r = 0.322, P < 0.05). A multivariate linear regression analysis demonstrated that the improvement in the FMD is associated with the plasma adiponectin (P < 0.05). The treatment of type 2 diabetes mellitus patients with sitagliptin reverses vascular endothelial dysfunction, as evidenced by increase in the FMD, and improvement of the adiponectin levels (UMIN Clinical Trials Registry System as trial ID UMIN000004236).
		                        		
		                        		
		                        		
		                        			Adiponectin/blood
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Atherosclerosis/complications/drug therapy
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/complications/*drug therapy
		                        			;
		                        		
		                        			Dipeptidyl-Peptidase IV Inhibitors/pharmacology/*therapeutic use
		                        			;
		                        		
		                        			Drug Administration Schedule
		                        			;
		                        		
		                        			Endothelium, Vascular/*drug effects/physiopathology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Nitroglycerin/therapeutic use
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Pyrazines/pharmacology/*therapeutic use
		                        			;
		                        		
		                        			Regression Analysis
		                        			;
		                        		
		                        			Triazoles/pharmacology/*therapeutic use
		                        			;
		                        		
		                        			Vasodilation/drug effects
		                        			;
		                        		
		                        			Vasodilator Agents/therapeutic use
		                        			
		                        		
		                        	
10.The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes.
Yoshiaki KUBOTA ; Masaaki MIYAMOTO ; Gen TAKAGI ; Takeshi IKEDA ; Sonoko KIRINOKI-ICHIKAWA ; Kotoko TANAKA ; Kyoichi MIZUNO
Journal of Korean Medical Science 2012;27(11):1364-1370
		                        		
		                        			
		                        			The vascular endothelial function is impaired in the very early stage of atherosclerosis in diabetic patients. The goal of this study was to identify the mechanism underlying the improvement in vascular endothelial function by sitagliptin in type 2 diabetes mellitus patients. This study was an open-labeled prospective observational single arm trial. Forty patients were treated with 50 mg of sitagliptin once daily for 12-weeks. The flow-mediated dilation (FMD) and plasma adiponectin were measured at baseline and 12 weeks after initiating treatment. The %FMD was significantly increased after treatment (4.13 +/- 1.59 vs 5.12 +/- 1.55, P < 0.001), whereas the nitroglycerin-mediated dilation (NMD) did not change. The plasma adiponectin levels significantly increased (13.0 +/- 11.3 vs 14.3 +/- 12.8, P < 0.001). The changes in the FMD were significantly correlated with those of the plasma adiponectin (r = 0.322, P < 0.05). A multivariate linear regression analysis demonstrated that the improvement in the FMD is associated with the plasma adiponectin (P < 0.05). The treatment of type 2 diabetes mellitus patients with sitagliptin reverses vascular endothelial dysfunction, as evidenced by increase in the FMD, and improvement of the adiponectin levels (UMIN Clinical Trials Registry System as trial ID UMIN000004236).
		                        		
		                        		
		                        		
		                        			Adiponectin/blood
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Atherosclerosis/complications/drug therapy
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/complications/*drug therapy
		                        			;
		                        		
		                        			Dipeptidyl-Peptidase IV Inhibitors/pharmacology/*therapeutic use
		                        			;
		                        		
		                        			Drug Administration Schedule
		                        			;
		                        		
		                        			Endothelium, Vascular/*drug effects/physiopathology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Nitroglycerin/therapeutic use
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Pyrazines/pharmacology/*therapeutic use
		                        			;
		                        		
		                        			Regression Analysis
		                        			;
		                        		
		                        			Triazoles/pharmacology/*therapeutic use
		                        			;
		                        		
		                        			Vasodilation/drug effects
		                        			;
		                        		
		                        			Vasodilator Agents/therapeutic use
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail